Académique Documents
Professionnel Documents
Culture Documents
http://dx.doi.org/10.5665/sleep.3920
Tsai-Chen Tsai, MD1; Jin-Shang Wu, MD, MS1,2; Yi-Ching Yang, MD, MPH1,2; Ying-Hsiang Huang, MD, MPH1; Feng-Hwa Lu, MD, MS1,2; Chih-Jen Chang, MD1,2
Department of Family Medicine, National Cheng Kung University Hospital, Tainan, Taiwan, ROC; 2Department of Family Medicine, College of
Medicine, National Cheng Kung University, Tainan, Taiwan, ROC
Study Objectives: We aimed to examine the association between sleep duration and arterial stiffness among adults of different ages, because to
date there has been only one study on this relationship, which was confined to middle-aged civil servants.
Design: Cross-sectional study.
Setting: A health examination center in National Cheng Kung University Hospital, Taiwan.
Participants: A total of 3,508 subjects, age 2087 y, were enrolled after excluding those with a history of cerebrovascular events, coronary artery
disease, peripheral artery disease, and taking lipid-lowering drugs, antihypertensives, hypoglycemic agents, and anti-inflammatory drugs, from
October 2006 to August 2009.
Interventions: N/A.
Measurements and Results: Sleep duration was classified into three groups: short (< 6 h), normal (68 h) and long (> 8 h). Arterial stiffness
was measured by brachial-ankle pulse-wave velocity (baPWV), and increased arterial stiffness was defined as baPWV 1400 cm/sec. The sleep
duration was different for subjects with and without increased arterial stiffness in males, but not in females. In the multivariate analysis for males,
long sleepers (odds ratio [OR] 1.75, P = 0.034) but not short sleepers (OR 0.98, P = 0.92) had a higher risk of increased arterial stiffness. In addition,
age, estimated glomerular filtration rate, hypertension, diabetes, total cholesterol/high-density lipoprotein cholesterol ratio, cigarette smoking, and
exercise were also independently associated factors. However, in females, neither short nor long sleep duration was associated with increased
arterial stiffness.
Conclusions: Long sleep duration was associated with a higher risk of increased arterial stiffness in males. Short sleepers did not exhibit a
significant risk of increased arterial stiffness in either sex.
Keywords: arterial stiffness, brachial-ankle pulse-wave velocity, cardiovascular disease, sleep duration
Citation: Tsai TC, Wu JS, Yang YC, Huang YH, Lu FH, Chang CJ. Long sleep duration associated with a higher risk of increased arterial stiffness
in males. SLEEP 2014;37(8):1315-1320.
INTRODUCTION
Epidemiological studies show that both short and long sleep
duration are associated with increased risk of obesity, diabetes,
hypertension, cardiovascular disease, and all-cause mortality.13
The mechanism of the association between sleep duration and
cardiovascular disease remains unclear, although previous
studies show that changes in sleep duration are associated with
metabolic alteration,4 increased sympathetic nervous activity,5
and inflammatory pathways.6,7 Because increased arterial
stiffness is also a predictor of fatal and nonfatal cardiovascular events and all-cause mortality,811 it can be seen as a link
between sleep duration and cardiovascular outcomes.
Arterial stiffness is associated with atherosclerosis at various
sites in the vascular tree.1214 Arterial stiffness is mainly caused
by stimulation of an inflammatory process, overproduction
of abnormal collagen, and decreased quantities of normal
elastin.15 Of the several noninvasive methods available to
assess arterial stiffness, pulse-wave velocity (PWV) is the most
1315
RESULTS
Table 1 shows the comparisons of clinical characteristics
between subjects with and without increased baPWV by sex. In
both sexes, subjects with increased arterial stiffness were older;
had a higher systolic and diastolic blood pressure, fasting plasma
glucose, total cholesterol, TC/HDL-C ratio, and prevalences of
hypertension and diabetes mellitus; and lower eGFR than those
without increased arterial stiffness. In addition, BMI, triglycerides, HDL-C, and alcohol drinking were signicantly different
between female subjects with and without increased arterial stiffness. However, the sleep duration was different between subjects
with and without increased arterial stiffness in males only.
In males, based on ANCOVA, Figure 1 showed that long
sleepers had a higher baPWV value than normal sleepers
(adjusted mean: 1413.6 17.8 versus 1348.9 4.2 cm/
sec, P < 0.001). There was no significant difference in
baPWV between short and normal sleepers (adjusted mean:
1342.2 10.3 versus 1348.9 4.2 cm/sec, P = 0.547). As for
females, the baPWV values in normal, short, and long sleepers
were 1266.0 5.1, 1275.0 11.8, and 1297.3 19.7cm/sec,
respectively. There were no significant differences in baPWV
among these three groups.
The results of the multiple logistic regression analysis on
the relationship between sleep duration and baPWV in males
and females are summarized in Table 2. In males, long sleepers
(OR = 1.75, 95% confidence interval [CI] = 1.042.94), but not
short sleepers (OR = 0.98, 95% CI = 0.721.35), had a higher
risk of increased arterial stiffness after adjusting for other variables. In addition, age of 4059 y versus younger than 40 y, age
60 y or older versus younger than 40 y, lower eGFR, hypertension, diabetes, TC/HDL-C ratio > 5, and cigarette smoking
were independently associated with increased arterial stiffness,
and regular exercise had an inverted relationship. In females,
although age 4059 y versus younger than 40 y, age 60 y or
older versus younger than 40 y, BMI, hypertension and TC/
HDL-C ratio were the independently associated factors, both
short and long sleep duration were not related to increased arterial stiffness.
DISCUSSION
Our results revealed that long sleep duration is associated with a higher risk of increased arterial stiffness in males,
whereas no significant association was found for short sleepers
of either sex, after adjusting for the potential confounding
factors in a Taiwanese population. To the best of our knowledge,
there has only been one cross-sectional study on the relationship between sleep duration and arterial stiffness as measured
by baPWV.23 However, the study subjects in that study were
mainly males, and confined to middle-aged Japanese civil
servants. In addition, subjects with medications that would
influence arterial stiffness were not excluded. In contrast, our
study excluded subjects taking lipid-lowering drugs, antihypertensive agents, hypoglycemic agents, and anti-inflammatory
drugs because previous research showed that arterial stiffness is
mainly caused by an inflammatory process,15 and that a variety
of pharmacological treatments are associated with changes in
arterial stiffness.25
The results of the logistic regression analyses carried out in
this work showed that only long sleep duration was associated
1316
Table 1Clinical characteristics of study subjects with and without increased arterial stiffness by sex
baPWV in Males
Age (y)
Age group (y)
< 40
4059
60
Body mass index (kg/m2)
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)
Creatinine (mg/dL)
eGFR (ml/min/1.73 m2)
Fasting plasma glucose (mg/dL)
Total cholesterol (mg/dL)
Triglyceride (mg/dL)
HDL-C (mg/dL)
TC/HDL-C > 5
Sleep duration (hours)
<6
68
>8
Snoring 3/w
Hypertension
Diabetes mellitus
Smoking
Alcohol drinking
Regular exercise 3/w
P value
< 1400cm/s
(n = 1,418)
42.3 9.6
1400 cm/s
(n = 677)
52.7 11.1
547 (38.6)
823 (58.0)
48 (3.4)
24.7 3.3
115.9 10.3
69.7 8.3
0.96 0.12
93.3 15.1
88.6 18.8
195.1 35.8
136.5 94.3
47.0 11.5
377 (26.6)
75 (11.1)
433 (64.0)
169 (25.0)
24.8 3.1
130.1 15.5
79.6 10.4
0.99 0.35
88.1 16.0
94.9 24.6
204.3 36.6
144.1 93.0
47.0 12.1
227 (33.5)
188 (13.3)
1184 (83.5)
46 (3.2)
352 (24.6)
60 (4.2)
54 (3.8)
325 (22.9)
365 (25.7)
209 (14.7)
94 (13.9)
532 (78.6)
51 (7.5)
175 (24.4)
213 (31.5)
88 (13.0)
172 (25.4)
175 (25.8)
84 (12.4)
< 0.001
< 0.001
0.216
< 0.001
< 0.001
0.009
< 0.001
< 0.001
< 0.001
0.085
0.957
0.001
< 0.001
0.978
< 0.001
< 0.001
0.211
0.958
0.150
baPWV in Females
< 1400cm/s
(n = 1,094)
42.3 9.7
1400 cm/s
(n = 319)
55.9 9.4
423 (38.7)
635 (58.0)
36 (3.3)
22.2 3.3
106.1 11.0
61.7 8.0
0.69 0.19
102.4 18.3
85.1 12.3
189.9 34.3
89.5 53.4
60.1 14.3
53 (4.8)
12 (3.8)
208 (65.2)
99 (31.0)
23.8 3.3
128.6 16.5
73.9 10.0
0.73 0.38
94.6 20.0
93.6 27.4
206.8 41.3
124.3 84.6
57.3 14.6
48 (15.0)
165 (15.1)
876 (80.1)
53 (4.8)
102 (9.3)
16 (1.5)
29 (2.7)
35 (3.2)
53 (4.8)
99 (9.0)
45 (14.1)
250 (74.4)
24 (7.5)
39 (11.5)
96 (30.1)
39 (12.2)
4 (1.3)
4 (1.3)
33 (10.3)
P value
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
0.150
< 0.001
< 0.001
< 0.001
< 0.001
0.002
< 0.001
0.174
0.354
< 0.001
< 0.001
0.062
0.004
0.484
Data are expressed as means standard deviation or numbers (percentage). baPWV, brachial-ankle pulse-wave velocity; eGFR, estimated glomerular
filtration rate; HDL-C, high-density lipoprotein-cholesterol; TC, total cholesterol.
1317
baPWV (cm/s)
baPWV (cm/s)
1318
1319
1320
48. Wang TD, Chen WJ, Chien KL, et al. Efficacy of cholesterol levels and
ratios in predicting future coronary heart disease in a Chinese population.
Am J Cardiol 2001;88:73743.
49. Wilkinson I, Cockcroft JR. Cholesterol, lipids and arterial stiffness. Adv
Cardiol 2007;44:26177.
50. Mazzone T, Chait A, Plutzky J. Cardiovascular disease risk in
type 2 diabetes mellitus: insights from mechanistic studies. Lancet
2008;371:18009.
51. Li CH, Wu JS, Yang YC, Shih CC, Lu FH, Chang CJ. Increased arterial
stiffness in subjects with impaired glucose tolerance and newly diagnosed
diabetes but not isolated impaired fasting glucose. J Clin Endocrinol
Metab 2012;97:E65862.
52. Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the
metabolic syndrome: a pathway to cardiovascular disease. Diabetologia
2008;51:52739.
53. Lee AT, Cerami A. Role of glycation in aging. Ann N Y Acad Sci
1992;663:6370.
54. Wildman RP, Mackey RH, Bostom A, Thompson T, Sutton-Tyrrell K.
Measures of obesity are associated with vascular stiffness in young and
older adults. Hypertension 2003;42:46873.
55. Tuttolomondo A, Di Raimondo D, Di Sciacca R, et al. Arterial stiffness
and ischemic stroke in subjects with and without metabolic syndrome.
Atherosclerosis 2012;225:2169.
56. Tomiyama H, Yamashina A, Arai T, et al. Influences of age and gender on
results of noninvasive brachial-ankle pulse wave velocity measurementa
survey of 12517 subjects. Atherosclerosis 2003;166:3039.
57. Budimir D, Jeroncic A, Gunjaca G, Rudan I, Polasek O, Boban M. Sexspecific association of anthropometric measures of body composition
with arterial stiffness in a healthy population. Med Sci Monit
2012;18:CR6571.
58. Rodrigues SL, Baldo MP, Lani L, Nogueira L, Mill JG, Sa Cunha R. Body
mass index is not independently associated with increased aortic stiffness
in a Brazilian population. Am J Hypertens 2012;25:10649.
59. Briet M, Burns KD. Chronic kidney disease and vascular remodelling:
molecular mechanisms and clinical implications. Clin Sci (Lond)
2012;123:399416.
60. Moody WE, Edwards NC, Chue CD, Ferro CJ, Townend JN. Arterial
disease in chronic kidney disease. Heart 2013;99:36572.
61. Doonan RJ, Hausvater A, Scallan C, Mikhailidis DP, Pilote L,
Daskalopoulou SS. The effect of smoking on arterial stiffness. Hypertens
Res 2010;33:398410.
62. Tanaka H, Safar ME. Influence of lifestyle modification on arterial
stiffness and wave reflections. Am J Hypertens 2005;18:13744.
63. Lauderdale DS, Knutson KL, Yan LL, Liu K, Rathouz PJ. Self-reported
and measured sleep duration: how similar are they? Epidemiology
2008;19:83845.
64. Fiorentini A, Valente R, Perciaccante A, Tubani L. Sleeps quality
disorders in patients with hypertension and type 2 diabetes mellitus. Int J
Cardiol 2007;114:E502.
65. Bruno RM, Palagini L, Gemignani A, et al. Poor sleep quality and
resistant hypertension. Sleep Med 2013;14:115763.
66. Phillips CL, Butlin M, Wong KK, Avolio AP. Is obstructive sleep apnoea
causally related to arterial stiffness? A critical review of the experimental
evidence. Sleep Med Rev 2013;17:718.